Milestones and accomplishments

Marcus Conant and Paul Volberding 1981
1981

Paul Volberding, MD, and others begin treating a growing number of gay men suffering from Kaposi's sarcoma at SF General Hospital.

Jay Levy 1980s
1983

Paul Volberding, MD; the late Constance Wofsy, MD; Donald Abrams, MD; and others create the world's first dedicated AIDS clinic in-patient facility, Ward 86, at SFGH.

Jay Levy, MD, discovers HIV at the same time as researchers at the Pasteur Institute in Paris, France.

John and Deborah Greenspan 1984
1984

John Greenspan, BDS, PhD, and Deborah Greenspan, DSc, BDS, are the first to describe a lesion known as hairy leukoplakia, often the first outward sign of AIDS.

1986

Drs. Tom Coates, Steve Hulley, Susan Kegeles and Leon McKusick establish the Center for AIDS Prevention Studies to conduct theory-based behavioral HIV/AIDS prevention research

Diane Wara
1987

Diane Wara, MD, co-founds the first center to care for pregnant women with HIV; within a decade, nearly all mother-to-child transmission is eliminated in California using a short course of antiviral drugs.

Charles Craik
1990

The laboratory of Charles Craik, PhD, is the first to use the X-ray structure of HIV protease to identify an inhibitor that blocks the enzyme's activity, leading to the design of lifesaving protease inhibitor drugs, which remain the standard of care today.

1996

Then UCSF School of Medicine Dean Dr. Haile Debas spearheads an effort to unite all HIV/AIDS programs and laboratories at UCSF, resulting in creation of the AIDS Research Institute

2000

Drs. Tom Coates and Michelle Roland develop a pioneering post-exposure prophylaxis (PEP) drug and counseling program (2000)

CoE on Transgender Health
2007

The UCSF Center of Excellence for Transgender Health is established to provide leadership, training, advocacy, and HIV-prevention resources for transgender individuals.

Robert Grant
2010

The iPrEx pre-exposure prophylaxis (PrEP) study led by Robert Grant, MD, MPH, is the first to show that use of AIDS drugs lowers the risk of infection.

UCSF's Diane Havlir, MD, leads a change to ART guidelines, recommending the offering of treatment to all who test HIV-positive.

Steve Deeks
2011

UCSF scientists Steven Deeks, MD; Mike McCune, MD, PhD; and Warner Greene, MD, PhD, are involved in two of three Martin Delaney Collaboratory grants awarded by the NIH to advance progress toward a cure for HIV.

Dr. Deeks is appointed co-chair of an international committee to explore scientific strategy toward eradication of latent HIV, effectively a cure.

Ward 86
2013

The HIV/AIDS Division at SFGH initiates the RAPID program to make antiretroviral treatment immediately available to those who test HIV-positive.

2014

UCSF leaders in the citywide Getting to Zero Consorium draft a strategic plan aimed at reducing new HIV infections, AIDS deaths, and stigma to zero in San Francisco

Photos: Levy and Wara by David Powers; Craik by Cindy Chew; Havlir by Steve Babuljak